Home / Economy / News / Coronavirus impact: Enough stock of hydroxychloroquine in India, says govt

Coronavirus impact: Enough stock of hydroxychloroquine in India, says govt

Joint Secretary in the Ministry of Health Lav Agarwal said that India has a stock of 3.28 crore tablets of hydroxychloroquine, which is three times more than the projected requirement

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical

Premium

India is the biggest manufacturer of the anti-malarial drug that is being touted as game changer in the fight against the Covid-19 pandemic.

Agencies New Delhi

2 min read Last Updated : Apr 11 2020 | 1:06 AM IST

The government on Friday said that there is enough stock of hydroxychloroquine (HCQ) in the country and it is taking all steps to ensure that there is no shortage of the drug in the domestic market.

Joint Secretary in the Ministry of Health Lav Agarwal said that India has a stock of 3.28 crore tablets of hydroxychloroquine, which is three time more than the projected requirement of one crore tablets in the country for the coming week and that tie-ups have been made for additional supply of 2 to 3 crore tablets for the future need.

“Based on our projected

Topics : Coronavirus Lockdown Health Ministry Donald Trump drug export Indian Pharmaceuticals Industry Narendra Modi

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in